While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Patients taking Ozempic ... 0.25 mg only approved for initiation and not maintenance),” a Novo Nordisk spokesperson said in ...

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

On Friday, Novo Nordisk A/S (NYSE:NVO) released headline results from part 1 of the ongoing ESSENCE Phase 3 trial, a 240-week ...

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

Participants were either given 2.4 mg of semaglutide ... to 7 percent for the lower-dose group and 3.4 percent for the placebo group. Ozempic is currently available in four dosages (0.25 mg ...

Clinical trial results have revealed that semaglutide treatment significantly reduced hospital admissions in overweight and ...

In the ESSENCE trial, semaglutide improved liver fibrosis in patients with metabolic dysfunction-associated steatohepatitis ...

Also Read: Ozempic Can Potentially ... data from the SOUL Phase 3 cardiovascular outcomes trial that evaluated subcutaneous once-weekly (injectable) semaglutide 2.4 mg. The trial achieved its ...

Phentermine may be effective for weight loss but may also have some side effects. Check out our reviews of the top ...